Desmopressin Acetate

醋酸去氨加压素

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameDesmopressin Acetate
Drug Alias NameDesmopresina去氨加压素醋酸酯制剂Desmopressine醋酸的斯加压素去氨基加压素 +[24] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVasopressin receptor agonists
TargetsVasopressin receptor
Therapy Area/IndicationsNocturiaHemorrhagevon Willebrand Disease, Type 1 +[17] 
Global Approved IndicationsNocturnal EnuresisDiabetes Insipidus, NeurogenicDiabetes Insipidus
Approved Indications in ChinaNocturnal EnuresisDiabetes Insipidus
Original Approved Country/TerritoryUnited States
Original Approved Date1978/02/21
Country/TerritoryCanadaUnited StatesSaudi Arabia +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFerring Bv
China Registration ClassN/A

Develop Information

Active CompaniesNordic PharmaImam Abdulrahman Bin Faisal UniversityEton Pharmaceuticals Inc +[8] 
Inactive CompaniesSerenity Pharmaceuticals IncSunnybrook Research InstituteChinese University Of Hong Kong (Cuhk) +[11] 
Active IndicationsHemorrhagevon Willebrand Disease, Type 1Hemophilia A +[7] 
Inactive IndicationsNocturiaTachycardiaRenal Insufficiency +[10] 

Other Information

ATC CodeH01BA02
Related LinksWikipediaDrugBankKEGG